Norway Osteoarthritis Injectables Market Size & Outlook

The osteoarthritis injectables market in Norway is expected to reach a projected revenue of US$ 67.9 million by 2030. A compound annual growth rate of 6.1% is expected of Norway osteoarthritis injectables market from 2024 to 2030.
Revenue, 2023 (US$M)
$44.9
Forecast, 2030 (US$M)
$67.9
CAGR, 2024 - 2030
6.1%
Report Coverage
Norway

Norway osteoarthritis injectables market, 2018-2030 (US$M)

Norway

Norway osteoarthritis injectables market highlights

  • The Norway osteoarthritis injectables market generated a revenue of USD 44.9 million in 2023 and is expected to reach USD 67.9 million by 2030.
  • The Norway market is expected to grow at a CAGR of 6.1% from 2024 to 2030.
  • In terms of segment, hyaluronic acid injections was the largest revenue generating injection type in 2023.
  • Hyaluronic Acid Injections is the most lucrative injection type segment registering the fastest growth during the forecast period.


Osteoarthritis injectables market data book summary

Market revenue in 2023USD 44.9 million
Market revenue in 2030USD 67.9 million
Growth rate6.1% (CAGR from 2023 to 2030)
Largest segmentHyaluronic acid injections
Fastest growing segmentHyaluronic Acid Injections
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCorticosteroid Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Acetylsalicylic Acid (ASA) Injections
Key market players worldwideAnika Therapeutics Inc, Bioventus Inc Class A, Ferring, Sanofi SA, Zimmer Biomet Holdings Inc, Arthrex, Pacira BioSciences Inc, Royal Biologics, Teva Pharmaceutical Industries Ltd


Other key industry trends

  • In terms of revenue, Norway accounted for 0.6% of the global osteoarthritis injectables market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany osteoarthritis injectables market is projected to lead the regional market in terms of revenue in 2030.
  • Denmark is the fastest growing regional market in Europe and is projected to reach USD 42.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Osteoarthritis Injectables Market Companies

Name Profile # Employees HQ Website

Norway osteoarthritis injectables market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to osteoarthritis injectables market will help companies and investors design strategic landscapes.


Hyaluronic acid injections was the largest segment with a revenue share of 38.75% in 2023. Horizon Databook has segmented the Norway osteoarthritis injectables market based on corticosteroid injections, hyaluronic acid injections, platelet-rich plasma (prp) injections, placental tissue matrix (ptm) injections, acetylsalicylic acid (asa) injections covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Norway osteoarthritis injectables market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Norway osteoarthritis injectables market databook

  • Our clientele includes a mix of osteoarthritis injectables market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Norway osteoarthritis injectables market , including forecasts for subscribers. This country databook contains high-level insights into Norway osteoarthritis injectables market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Norway osteoarthritis injectables market size, by injection type, 2018-2030 (US$M)

Norway Osteoarthritis Injectables Market Outlook Share, 2023 & 2030 (US$M)

Norway osteoarthritis injectables market size, by injection type, 2018-2030 (US$M)

Related regional statistics

No records

No related regions found.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more